[1] 朱洁云,高敏,宋秋韵,等.中国老年人骨质疏松症患病率的Meta分析[J].中国全科医学,2022,25(3):346-353.
[2] ALDINI NN, FINI M, GIAVARESI G, et al. Pedicular fixation in the osteoporotic spine: a pilot in vivo study on long-term ovariectomized sheep. J Orthop Res. 2002; 20(6):1217-1224.
[3] COE JD, WARDEN KE, HERZIG MA, et al. Influence of bone mineral density on the fixation of thoracolumbar implants. A comparative study of transpedicular screws, laminar hooks, and spinous process wires. Spine (Phila Pa 1976). 1990; 15(9):902-907.
[4] KAWAGUCHI Y. Genetic background of degenerative disc disease in the lumbar spine. Spine Surg Relat Res. 2018;2(2):98-112.
[5] CHEUNG KM, KARPPINEN J, CHAN D, et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976). 2009;34(9):934-940.
[6] DEYO RA, GRAY DT, KREUTER W, et al. United States trends in lumbar fusion surgery for degenerative conditions. Spine (Phila Pa 1976). 2005;30(12):1441-1445; discussion 1446-1447.
[7] KATZ JN. Lumbar spinal fusion. Surgical rates, costs, and complications. Spine (Phila Pa 1976). 1995;20(24 Suppl):78S-83S.
[8] HIRSCH BP, UNNANUNTANA A, CUNNINGHAM ME, et al. The effect of therapies for osteoporosis on spine fusion: a systematic review. Spine J. 2013;13(2): 190-199.
[9] OHTORI S, INOUE G, ORITA S, et al. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine (Phila Pa 1976). 2012;37(23): E1464-1468.
[10] OHTORI S, INOUE G, ORITA S, et al. Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976). 2013; 38(8):E487-492.
[11] 周晓清,陈晓钢,胡小吾,等.特立帕肽预防骨质疏松患者腰椎融合术后椎弓根螺钉松动的前瞻性研究[J].中国骨质疏松杂志,2014,20(3):285-287,296.
[12] EBATA S, TAKAHASHI J, HASEGAWA T, et al. Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders: A Multicenter, Prospective Randomized Study. J Bone Joint Surg Am. 2017;99(5): 365-372.
[13] 刘汉辉,赵晓东,陈光福,等.腰椎滑脱伴骨质疏松症患者TLIF术后应用特立帕肽治疗的临床研究[J].中国当代医药, 2018,25(19):12-16.
[14] USHIROZAKO H, HASEGAWA T, EBATA S, et al. Weekly Teriparatide Administration and Preoperative Anterior Slippage of the Cranial Vertebra Next to Fusion Segment < 2 mm Promote Osseous Union After Posterior Lumbar Interbody Fusion. Spine (Phila Pa 1976). 2019;44(5):E288-E297.
[15] JESPERSEN AB, ANDRESEN ADK, JACOBSEN MK, et al. Does Systemic Administration of Parathyroid Hormone After Noninstrumented Spinal Fusion Surgery Improve Fusion Rates and Fusion Mass in Elderly Patients Compared to Placebo in Patients With Degenerative Lumbar Spondylolisthesis? Spine (Phila Pa 1976). 2019;44(3):157-162.
[16] BURCH S, TALIAFERRO K, BERVEN SH, et al. Assessment of the efficacy of teriparatide (Forteo) in patients undergoing posterolateral lumbar spinal fusion: a double-blinded randomized pilot study. Spine Journal. 2019; 19(9):S81.
[17] OBA H, TAKAHASHI J, YOKOMICHI H, et al. Weekly Teriparatide Versus Bisphosphonate for Bone Union During 6 Months After Multi-Level Lumbar Interbody Fusion for Osteoporotic Patients: A Multicenter, Prospective, Randomized Study. Spine (Phila Pa 1976). 2020;45(13):863-871.
[18] COMPSTON JE, MCCLUNG MR, LESLIE WD. Osteoporosis. Lancet. 2019;393(10169):364-376.
[19] 杨埜,陈金忠,李野,等.FRAX工具预测桂西地区2型糖尿病患者骨折风险的相关性分析[J].中国骨质疏松杂志,2020, 26(4):560-563,577.
[20] SOLDOZY S, SARATHY D, SKAFF A, et al. Pharmacologic considerations in patients with osteoporosis undergoing lumbar interbody fusion: A systematic review. Clin Neurol Neurosurg. 2020;196:106030.
[21] DRAKOPOULOS P, FLEVAS DA, GALANOPOULOS IP, et al. Off-Label Use of Teriparatide in Spine. Cureus. 2021;13(7): e16522.
[22] 林红,李泽方,孟俊融,等.特立帕肽与唑来膦酸对合并骨质疏松的腰椎融合术的患者骨代谢与骨融合的对比研究[C].武汉:2019楚天骨科高峰论坛暨第二十六届中国中西医结合骨伤科学术年会论文集, 2019.
[23] 孟俊融,姜允琦,李熙雷,等.骨质疏松症患者行腰椎融合术后使用特立帕肽与唑来膦酸的对比研究[C].呼和浩特:第二十四届中国中西医结合骨伤科学术年会论文汇编,2017.
[24] SAAG KG, PETERSEN J, BRANDI ML, et al. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. N Engl J Med. 2017;377(15):1417-1427.
[25] YOLCU YU, ZREIK J, ALVI MA, et al. Use of teriparatide prior to lumbar fusion surgery lowers two-year complications for patients with poor bone health. Clin Neurol Neurosurg. 2020;198:106244.
[26] SUGIURA T, KASHII M, MATSUO Y, et al. Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis. Spine J. 2015;15(2):298-306.
|